Wyeth Prevails in Diet Drug Case

Press Release:

Press Release
News Article November 2003

Madison, N.J., November 26, 2003 - Wyeth (NYSE:WYE) announced today that the jury returned a unanimous verdict in the Company's favor in the case of Linda Eichmiller vs. American Home Products, et al. The trial of this back-end opt out case had begun on November 6 before Judge Constance Russell in the Superior Court of Fulton County in Atlanta, Georgia. The plaintiff alleged heart valve injury from the use of the diet drug Pondimin.

“The jury's decision was amply supported by the evidence presented in this case,” says Peter Bleakley, an attorney representing Wyeth. “We proved that there was insufficient information to suggest an association between diet drugs and valvular heart disease when the plaintiff began using the product. Furthermore, we clearly showed that the plaintiff's medical condition was caused by a number of factors and could not be narrowed to her use of the diet drug, Pondimin. We also showed that surgery would not be required.”

Diet drugs will continue to be an issue that Wyeth will deal with aggressively, as the Company believes there are a significant number of cases that have no basis in law or fact.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products and nonprescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.

This press release is provided in good-faith by Chiltern Magazine Services Ltd ("CMS") as a service to users of www.telecomsinfo.com. Whilst all care is taken in sourcing and preparing material includede here, any error or incorrect content cannot form the basis for any legal action against the site-owner. Users are advised to check the accuracy of any statements before relying upon them. Likewise, any forward-looking statements made by the author of the press release should be treated as such.

CMS, P&A House, Alma Road, Chesham, Bucks. HP5 3HB, UK
Tel: +44 (0)1494 771734
Fax: +44 (0)1494 778994
e-mail: Editor, CMSinfo

For more information about us, visit CMSinfo.